Zusammenfassung
Die allergische bronchopulmonale Aspergillose ist eine seltene, oft erst spät diagnostizierte Atemwegs- und Lungenerkrankung, die auf dem Boden eines allergischen Asthma bronchiale entsteht. Die klinischen Zeichen purulentes Sputum, rezidivierende pulmonale Infiltrate wechselnder Ausprägung bei einer kutan und serologisch nachweisbaren IgE-abhängigen Sensibilisierung gegen A. fumigatus und rekombinante A.-fumigatus-Antigene (oder seltener anderen Schimmelpilzen), gepaart mit einer labortechnisch nachweisbaren, ausgeprägten Eosinophilie und hohen, polyklonalen gesamt-IgE-Titern und dem Nachweis von Bronchiektasen, Mucoid Impaction und fibrotischen Veränderungen sollten die Diagnose einer ABPA nahelegen. Die Therapie umfasst immunsuppressive Behandlung mit systemischen und topischen Kortikosteroiden, Antimykotika und in Zukunft möglicherweise die Immuntherapie mit Anti-IgE- und/oder Anti-Zytokin-Antikörpern. Gesamt-IgE-Spiegel sind zur Therapiesteuerung geeignet.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Saikia B, Chakrabarti A et al (2010) Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Respir Med 104(2):204–210
Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R et al (2013a) Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy 43(8):850–873
Agarwal R, Maskey D, Aggarwal AN, Saikia B, Garg M, Gupta D et al (2013b) Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS ONE 8(4):e61105. Doherty TM, Herausgeber
Agarwal R, Aggarwal AN, Sehgal IS, Dhooria S, Behera D, Chakrabarti A (2015) Performance of serum galactomannan in patients with allergic bronchopulmonary aspergillosis. Mycoses 58(7):408–412
Alekseeva L, Huet D, Féménia F, Mouyna I, Abdelouahab M, Cagna A et al (2009) Inducible expression of beta defensins by human respiratory epithelial cells exposed to Aspergillus fumigatus organisms. BMC Microbiol 9(1):33
Altman MC, Lenington J, Bronson S, Ayars AG (2017) Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract 5(4):1137–1139
Araujo R, Amorim A, Gusmão L (2010) Genetic diversity of Aspergillus fumigatus in indoor hospital environments. Med Mycol 48(6):832–838
Aydın Ö, Sözener ZÇ, Soyyiğit Ş, Kendirlinan R, Gençtürk Z, Mısırlıgil Z et al (2015) Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: one center’s experience with 14 cases. Allergy Asthma Proc 36(6):493–500
Bains SN, Judson MA (2012) Allergic bronchopulmonary aspergillosis. Clin Chest Med 33(2):265–281
Balloy V, Sallenave J-M, Wu Y, Touqui L, Latgé J-P, Si-Tahar M et al (2008) Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the toll-like receptor-MyD88 pathway. J Biol Chem 283(45):30513–30521
Balter MS, Rebuck AS (1992) Treatment of allergic bronchopulmonary aspergillosis with inhaled corticosteroids. Respir Med 86(5):441–442
Beauvais A, Fontaine T, Aimanianda V, Latgé J-P (2014) Aspergillus cell wall and biofilm. Mycopathologia 178(5–6):371–377
Becker KL, Gresnigt MS, Smeekens SP, Jacobs CW, Magis-Escurra C, Jaeger M et al (2015) Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients. Clin Exp Allergy 45(2):423–437
Bellocchio S, Moretti S, Perruccio K, Fallarino F, Bozza S, Montagnoli C et al (2004) TLRs govern neutrophil activity in aspergillosis. J Immunol 173(12):7406–7415
Bonini M, Di Maria G, Paggiaro P, Rossi A, Senna G, Triggiani M et al (2014) Potential benefit of omalizumab in respiratory diseases. Ann Allergy Asthma Immunol 113(5):513–519
Bosken CH, Myers JL, Greenberger PA, Katzenstein A-LA (1988) Pathologic features of allergic bronchopulmonary aspergillosis. Am J Surg Pathol 12(3):216–222
Bromley IM, Donaldson K (1996) Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: relevance to the asthmatic lung. Thorax 51(12):1203–1209
Brummund W, Resnick A, Fink JN, Kurup VP (1987) Aspergillus fumigatus-specific antibodies in allergic bronchopulmonary aspergillosis and aspergilloma: evidence for a polyclonal antibody response. J Clin Microbiol 25(1):5–9
Chapman BJ, Capewell S, Gibson R, Greening AP, Crompton GK (1989) Pulmonary eosinophilia with and without allergic bronchopulmonary aspergillosis. Thorax 44(11):919–924
Chauhan B, Santiago L, Hutcheson PS, Schwartz HJ, Spitznagel E, Castro M et al (2000) Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 106(4):723–729
Chetty A (2003) Pathology of allergic bronchopulmonary aspergillosis. Front Biosci 8(5):e110–e114
Chishimba L, Langridge P, Powell G, Niven RM, Denning DW (2015) Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). J Asthma 52(3):289–295
Chowdhary A, Agarwal K, Kathuria S, Gaur SN, Randhawa HS, Meis JF (2014) Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview. Crit Rev Microbiol 40(1):30–48
Crameri R (1998) Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications. Int Arch Allergy Immunol 115(2):99–114
Croft CA, Culibrk L, Moore MM, Tebbutt SJ (2016) Interactions of Aspergillus fumigatus conidia with airway epithelial cells: a critical review. Front Microbiol [Internet]. 7. April 2016 [zitiert 5. Februar 2021];7. Verfügbar unter: http://journal.frontiersin.org/Article/10.3389/fmicb.2016.00472/abstract
Denning DW, O’Driscoll BR, Powell G, Chew F, Atherton GT, Vyas A et al (2009) Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med 179(1):11–18
Denning DW, Pleuvry A, Cole DC (2013) Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 51(4):361–370
Dhooria S, Agarwal R (2014) Diagnosis of allergic bronchopulmonary aspergillosis: a case-based approach. Future Microbiol 9(10):1195–1208
van der Ent CK, Hoekstra H, Rijkers GT (2007) Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 62(3):276–277
Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, Nota R et al (2002) Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 420(6912):182–186
Gauthier T, Wang X, Sifuentes Dos Santos J, Fysikopoulos A, Tadrist S, Canlet C et al (2012) Trypacidin, a spore-borne toxin from Aspergillus fumigatus, is cytotoxic to lung cells. PLoS ONE 7(2):e29906. Filler SG, Herausgeber
Geissler A, Haun F, Frank DO, Wieland K, Simon MM, Idzko M et al (2013) Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK. Cell Death Differ 20(10):1317–1329
Gibson PG, Wark PAB, Simpson JL, Meldrum C, Meldrum S, Saltos N et al (2003) Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis. Eur Respir J 21(4):582–588
Godet C, Meurice J-C, Roblot F, Kauffmann-Lacroix C, Verdaguer M, Frat J-P et al (2012) Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA: figure 1. Eur Respir J 39(5):1261–1263
Gomez P, Hackett TL, Moore MM, Knight DA, Tebbutt SJ (2010) Functional genomics of human bronchial epithelial cells directly interacting with conidia of Aspergillus fumigatus. BMC Genomics 11(1):358
Graves TS (1979) A familial occurrence of allergic bronchopulmonary aspergillosis. Ann Intern Med 91(3):378
Greenberger P, Patterson R (1987) Allergic bronchopulmonary aspergillosis. Model of bronchopulmonary disease with defined serologic, radiologic, pathologic and clinical findings from asthma to fatal destructive lung disease. Chest 91(6 Suppl):165S–171S
Greenberger P, Smith L, Hsu C, Roberts M, Liotta J (1988) Analysis of bronchoalveolar lavage in allergic bronchopulmonary aspergillosis: divergent responses of antigen-specific antibodies and total IgE. J Allergy Clin Immunol 82(2):164–170
Greenberger PA (1994) Diagnosis and management of allergic bronchopulmonary aspergillosis. Allergy Asthma Proc 15(6):335–339
Greenberger PA (2002) Allergic bronchopulmonary aspergillosis, allergic fungal sinusitis, and hypersensitivity pneumonitis. Clin Allergy Immunol 16:449–468
Greenberger PA (2012) Chapter 18: allergic bronchopulmonary aspergillosis. Allergy Asthma Proc 33(3):61–63
Greenberger PA, Patterson R (1988) Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol 81(4):646–650
Greenberger PA, Bush RK, Demain JG, Luong A, Slavin RG, Knutsen AP (2014) Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract 2(6):703–708
Hansell DM, Strickland B (1989) High-resolution computed tomography in pulmonary cystic fibrosis. Br J Radiol 62(733):1–5
Hemmann S, Menz G, Ismail C, Blaser K, Crameri R (1999) Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A fumigatus–sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization. J Allergy Clin Immunol 104(3):601–607
Henderson AH (1968) Allergic aspergillosis: review of 32 cases. Thorax 23(5):501–512
Hinson KFW, Moon AJ, Plummer NS (1952) Broncho-pulmonary aspergillosis: a review and a report of eight new cases. Thorax 7(4):317–333
Hogan C, Denning D (2011) Allergic bronchopulmonary aspergillosis and related allergic syndromes. Semin Respir Crit Care Med 32(06):682–692
Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC et al (2009) Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure1. Emerg Infect Dis 15(7):1068–1076
Imbeault B, Cormier Y (1993) Usefulness of inhaled high-dose corticosteroids in allergic bronchopulmonary aspergillosis. Chest 103(5):1614–1617
Kauffman H, Beaumont F, Demonchy J, Sluiter H, Devries K (1984) Immunologic studies in bronchoalveolar fluid in a patient with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 74(6):835–840
Kaur S, Gupta VK, Thiel S, Sarma PU, Madan T (2007) Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Clin Exp Immunol 148(2):382–389
Kirsten D, Nowak D, Rabe KF, Magnussen H (1993) Diagnosis of bronchopulmonary aspergillosis is often made too late. Med Klin Munich 88:353–356
Knutsen AP, Slavin RG (2011) Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol 2011:1–13
Kono Y, Tsushima K, Yamaguchi K, Kurita N, Soeda S, Fujiwara A et al (2013) The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis. Respir Med 107(7):1094–1100
Laoudi Y, Paolini J-B, Grimfed A, Just J (2008) Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA? Eur Respir J 31(4):908–909
Latgé J-P (2001) The pathobiology of Aspergillus fumigatus. Trends Microbiol 9(8):382–389
Logan P, Muller N (1996a) CT manifestations of pulmonary aspergillosis. Crit Rev Diagn Imaging 37:1–37
Logan P, Muller N (1996b) High-attenuation mucous plugging in allergic bronchopulmonary aspergillosis. Can Assoc Radiol J 47:374–377
Malo JL, Inouye T, Hawkins R, Simon G, Turner-Warwick M, Pepys J (1977) Studies in chronic allergic bronchopulmonary aspergillosis. 4. Comparison with a group of asthmatics. Thorax 32(3):275–280
Matsuura H, Fujiwara K, Omori H, Onishi K, Kuribayashi T, Mitsumune S et al (2021) Successful treatment with benralizumab for allergic bronchopulmonary aspergillosis that developed after disastrous heavy rainfall in western Japan. Intern Med [Internet]. https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_6217-20/_article. Zugegriffen am 06.02.2021.
McCarthy DS, Pepys J (1971) Allergic broncho-pulmonary aspergillosis Clinical immunology: (2) Skin, nasal and bronchial tests. Clin Exp Allergy 1(4):415–432
McCarthy DS, Simon G, Hargreave FE (1970) The radiological appearances in allergic broncho-pulmonary aspergillosis. Clin Radiol 21(4):366–375
Mintzer RA, Rogers LF, Kruglik GD, Rosenberg M, Neiman HL, Patterson R (1978) The spectrum of radiologic findings in allergic bronchopulmonary aspergillosis. Radiology 127(2):301–307
Moss RB (2005) Pathophysiology and immunology of allergic bronchopulmonary aspergillosis. Med Mycol 43(s1):203–206
Moss RB (2014) Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis. Eur Respir J 43(5):1487–1500
Mullins J, Seaton A (1978) Fungal spores in lung and sputum. Clin Exp Allergy 8(5):525–533
Murphy D, Lane DJ (1981) Pleural effusion in allergic bronchopulmonary aspergillosis: two case reports. Br J Dis Chest 75(1):91–95
Neeld DA, Goodman LR, Gurney JW, Greenberger PA, Fink JN (1990) Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 142(5):1200–1205
Neveu WA, Bernardo E, Allard JL, Nagaleekar V, Wargo MJ, Davis RJ et al (2011) Fungal allergen β-glucans trigger p38 mitogen-activated protein kinase–mediated IL-6 translation in lung epithelial cells. Am J Respir Cell Mol Biol 45(6):1133–1141
Panaccione DG, Coyle CM (2005) Abundant respirable ergot alkaloids from the common airborne fungus Aspergillus fumigatus. Appl Environ Microbiol 71(6):3106–3111
Panchal N, Pant C, Bhagat R, Shah A (1994) Central bronchiectasis in allergic bronchopulmonary aspergillosis: comparative evaluation of computed tomography of the thorax with bronchography. Eur Respir J 7(7):1290–1293
Panchal N, Bhagat R, Pant C, Shah A (1997) Allergic bronchopulmonary aspergillosis: the spectrum of computed tomography appearances. Respir Med 91(4):213–219
Parisi GF, Portale A, Papale M, Tardino L, Rotolo N, Licari A et al (2019) Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: case reports and literature review. J Allergy Clin Immunol Pract 7(5):1636–1638
Pasqualotto AC, Denning DW (2007) Generic substitution of itraconazole resulting in sub-therapeutic levels and resistance. Int J Antimicrob Agents 30(1):93–94
Patterson K, Strek ME (2010) Allergic bronchopulmonary aspergillosis. Proc Am Thorac Soc 7(3):237–244
Patterson R (1986) Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 146(5):916–918
Paulussen C, Hallsworth JE, Álvarez-Pérez S, Nierman WC, Hamill PG, Blain D et al (2017) Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species. Microb Biotechnol 10(2):296–322
Perfect JR, Cox GM, Lee JY, Kauffman CA, de Repentigny L, Chapman SW et al (2001) The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 33(11):1824–1833
Phelan MS, Kerr IH (1984) Allergic broncho-pulmonary aspergillosis: the radiological appearance during long-term follow-up. Clin Radiol 35(5):385–392
Ramonell RP, Lee FE-H, Swenson C, Kuruvilla M (2020) Dupilumab treatment for allergic bronchopulmonary aspergillosis: a case series. J Allergy Clin Immunol Pract 8(2):742–743
Ricketti A, Greenberger P, Patterson R (1984) Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 74(1):68–71
Rincon M, Irvin CG (2012) Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci 8(9):1281–1290
Ritz N, Ammann RA, Casaulta Aebischer C, Schoeni-Affolter F, Schoeni MH (2005) Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis. Eur J Pediatr 164(9):577–582
Rosenberg IL, Greenberger PA (1984) Allergic bronchopulmonary aspergillosis and aspergilloma. Chest 85(1):123–125
Rosenberg M, Patterson R, Roberts M, Wang J (1978) The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. Am J Med 64(4):599–606
Saxena S, Madan T, Shah A, Muralidhar K, Sarma PU (2003) Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 111(5):1001–1007
Schleich F, Vaia E-S, Pilette C, Vandenplas O, Halloy J-L, Michils A et al (2020) Mepolizumab for allergic bronchopulmonary aspergillosis: report of 20 cases from the Belgian Severe Asthma Registry and review of the literature. J Allergy Clin Immunol Pract 8(7):2412–2413.e2
Schwartz H, Citron K, Chester E, Kaimal J, Barlow P, Baum G et al (1978) A comparison of the prevalence of sensitization to antigens among asthmatics in Cleveland and London. J Allergy Clin Immunol 62(1):9–14
Serisier DJ, Martin ML (2011) Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations. Respir Med 105(6):946–949
Shah A, Panjabi C (2014) Allergic aspergillosis of the respiratory tract. Eur Respir Rev 23(131):8–29
Skov M, Pressler T, Jensen HE, Hoiby N, Koch C (1999) Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 54(1):44–50
Slavin RG, Gleich GJ, Hutcheson PS, Kephart GM, Knutsen AP, Tsai CC (1992) Localization of IgE to lung germinal lymphoid follicles in a patient with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 90(6):1006–1008
Soeda S, Kono Y, Tsuzuki R, Yamawaki S, Katsube O, To M et al (2019) Allergic bronchopulmonary aspergillosis successfully treated with benralizumab. J Allergy Clin Immunol Pract 7(5):1633–1635
Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A et al (2000) A Randomized Trial of Itraconazole in Allergic Bronchopulmonary Aspergillosis. N Engl J Med 342(11):756–762
Terashima T, Shinozaki T, Iwami E, Nakajima T, Matsuzaki T (2018) A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab. BMC Pulm Med 18(1):53
Tillie-Leblond I, Germaud P, Leroyer C, Tétu L, Girard F, Devouassoux G et al (2011) Allergic bronchopulmonary aspergillosis and omalizumab: ALLERGY Net. Allergy 66(9):1254–1256
Tomee J, Kauffman H, Klimp A, Demonchy J, Koeter G, Dubois A (1994) Immunologic significance of a collagen-derived culture filtrate containing proteolytic activity in -related diseases. J Allergy Clin Immunol 93(4):768–778
Tomee JFC, Wierenga ATJ, Hiemstra PS, Kauffman HF (1997) Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 176(1):300–303
Tomee K (2000) Putative virulence factors of Aspergillus fumigatus: putative virulence factors of Aspergillus fumigatus. Clin Exp Allergy 30(4):476–484
Tsubouchi K, Arimura-Omori M, Inoue S, Okamatsu Y, Inoue K, Harada T (2021) A case of allergic bronchopulmonary aspergillosis with marked peripheral blood eosinophilia successfully treated with benralizumab. Respir Med Case Rep 32:101339
Virchow JC (2011) Allergische Bronchopulmonale Aspergillose. In: W. Heppt, C. Bachert, Praktische Allergologie, 2. Aufl, Georg Thieme, Stuttagart, Seiten 56–64
Vlahakis NE, Aksamit TR (2001) Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc 76(9):930–938
Voskamp AL, Gillman A, Symons K, Sandrini A, Rolland JM, O’Hehir RE et al (2015) Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract 3(2):192–199
Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F et al (1994) Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 150(4):1038–1048
Wark PAB, Saltos N, Simpson J, Slater S, Hensley MJ, Gibson PG (2000) Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J 16(6):1095–1101
Webb W, Muller N, Naidich D (2009) High-resolution CT of the lung, 4. Aufl. Lippincott, Williams & Wilkinis, Philadelphia
Whitaker P, Brownlee K, Lee T, Conway S, Etherington C, Peckham D (2011) Sequential bronchoscopy in the management of lobar atelectasis secondary to allergic bronchopulmonary aspergillosis. J Bronchol Interv Pulmonol 18(1):57–60
Zhang Z, Liu R, Noordhoek JA, Kauffman HF (2005) Interaction of airway epithelial cells (A549) with spores and mycelium of Aspergillus fumigatus. J Infect 51(5):375–382
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Virchow, J.C. (2022). Allergische bronchopulmonale Aspergillose. In: Kreuter, M., Costabel, U., Herth, F.J., Kirsten, D. (eds) Seltene Lungenerkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-63651-0_34
Download citation
DOI: https://doi.org/10.1007/978-3-662-63651-0_34
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-63650-3
Online ISBN: 978-3-662-63651-0
eBook Packages: Medicine (German Language)